A Case Report of Sedation Strategy for a Patient With Coronavirus Disease 2019 Supported by Extracorporeal Membrane Oxygenation After Cesarean Section.
Heart Surg Forum
; 24(1): E019-E021, 2021 01 14.
Article
in English
| MEDLINE | ID: covidwho-1079393
ABSTRACT
Pneumonia caused by coronavirus disease 2019 (COVID-19) is a highly contagious disease. Unfortunately, research on extracorporeal membrane oxygenation (ECMO) assisted treatments for patients with COVID-19 infection is limited. In this case study, a patient who was in late pregnancy (35+2 weeks of pregnancy) and suffering from severe COVID-19 was extremely irritable during ECMO-assisted treatment after she underwent a cesarean section. Her Richmond Agitation Sedation Scale (RASS) score reached +3. Nevertheless, the patient successfully was treated with a continuous single/combined application of propofol, midazolam, dexmedetomidine, hibernation mixture, and other drugs for several days (maintaining RASS -2 to -4) and provided with anti-infection, mechanical ventilation, nutritional support, fluid balance under hemodynamic monitoring, liver support, and other organ function support treatments. ECMO-assisted sedation strategy for patients was introduced and discussed in this case to provide a certain reference for the clinical diagnosis and treatment of such patients.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Midazolam
/
Extracorporeal Membrane Oxygenation
/
Propofol
/
Cesarean Section
/
Dexmedetomidine
/
COVID-19
/
Hypnotics and Sedatives
Type of study:
Case report
/
Prognostic study
Limits:
Female
/
Humans
/
Pregnancy
Language:
English
Journal:
Heart Surg Forum
Journal subject:
Cardiology
Year:
2021
Document Type:
Article
Affiliation country:
Hsf.3459
Similar
MEDLINE
...
LILACS
LIS